Tuberculosis chemotherapy: The influence of bacillary stress and damage response pathways on drug efficacy

Clinical Microbiology Reviews

Volumn 19, Issue 3, 2006, Pages 558-570

  Warner, Digby F ^a   Mizrahi, Valerie ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

BACILLUS; BACTERIAL MUTATION; DIRECTLY OBSERVED THERAPY; DNA DAMAGE; DRUG EFFICACY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; DNA DAMAGE; DRUG RESISTANCE, BACTERIAL; HEAT-SHOCK RESPONSE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TREATMENT OUTCOME; TUBERCULOSIS;

BACILLI (CLASS); MYCOBACTERIUM TUBERCULOSIS;

EID: 33746493349     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00060-05     Document Type: Review

References (262)

1. Adams, L. B., M. C. Dinauer, D. E. Morgenstern, and J. L. Krahenbuhl. 1997. Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuber. Lung Dis. 78:237-246.
2. Ainsa, J. A., M. C. Blokpoel, I. Otal, D. B. Young, K. A. De Smet, and C. Martin. 1998. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J. Bacteriol. 180:5836-5843.
3. Akaki, T., H. Tomioka, T. Shimizu, S. Dekio, and K. Sato. 2000. Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the anti-microbial activity of macrophages against Mycobacterium tuberculosis. Clin. Exp. Immunol. 121:302-310.
4. Alonso, A., E. Campanario, and J. L. Martínez. 1999. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 145:2857-2862.
5. Andersson, D. I. 2003. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6:452-456.
6. Andersson, D. I., and B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493.
7. Arcus, V. L., P. B. Rainey, and S. J. Turner. 2005. The PIN-domain toxin-antitoxin array in mycobacteria. Trends Microbiol. 13:360-365.
8. Artsimovitch, I., V. Patian, S. Sekine, M. N. Vassylyeva, T. Hosaka, K. Ochi, S. Yokoyama, and D. G. Vassylyev. 2004. Structural basis for transcription regulation by alarmone ppGpp. Cell 117:299-310.
9. Balahan, N. Q., J. Merrin, R. Chait, L. Kowalik, and S. Leihler. 2004. Bacterial persistence as a phenotypic switch. Science 305:1622-1625.
10. Baquero, F., and M. C. Negri. 1997. Selective compartments for resistant microorganisms in antibiotic gradients. Bioessays 19:731-736.
11. Baquero, F., M. C. Negri, M. I. Morosini, and J. Blazquez. 1998. Antibiotic-selective environments. Genetics 27:S5-S11.
12. Barker, M. M., T. Gaal, C. A. Josaitis, and R. L. Gourse. 2001. Mechanisms of regulation of transcription initiation by ppGpp. I. Effects of ppGpp on transcription initiation in vivo and in vitro. J. Mol. Biol. 305:673-688.
13. Barry, C. E., III, and K. Mdluli. 1996. Drug sensitivity and environmental adaptation of mycobacterial cell wall components. Trends Microbiol. 4:275-281.
14. Betts, J. C., P. T. Lukey, L. C. Robb, R. A. McAdam, and K. Duncan. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-731.
15. Bigger, J. W. 1944. Treatment of staphylococcal infections with penicillin. Lancet ii:497-500.
16. Billington, O. J., T. D. McHugh, and S. H. Gillespie. 1999. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:1866-1869.
17. Bjedov, I., O. Tenaillon, B. Gerard, V. Souza, E. Denamur, M. Radman, F. Taddei, and I. Matic. 2003. Stress-induced mutagenesis in bacteria. Science 300:1404-1409.
18. Björkholm, B., M. Sjolund, P. G. Falk, O. G. Berg, L. Engstrand, and D. I. Andersson. 2001. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc. Natl. Acad. Sci. USA 98:14607-14612.
19. Blower, S. M., and T. Chou. 2004. Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance. Nat. Med. 10:1111-1116.
20. Boe, L., M. Danielsen, S. Knudsen, J. B. Petersen, J. Maymann, and P. R. Jensen. 2000. The frequency of mutators in populations of E. coli. Mutat. Res. 448:47-55.
21. Boon, C., and T. Dick. 2002. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J. Bacteriol. 184:6760-6767.
22. Boshoff, H. I. M., and C. E. Barry III. 2005. Tuberculosis: metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3:70-80.
23. Boshoff, H. I. M., M. B. Reed, C. E. Barry III, and V. Mizrahi. 2003. DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis. Cell 113:183-193.
24. Boshoff, H. I. M., S. I. Durbach, and V. Mizrahi. 2001. DNA metabolism in Mycobacterium tuberculosis: implications for drug resistance and strain variability. Scand. J. Infect. Dis. 33:101-105.
25. Boshoff, H. I. M., T. G. Myers, B. R. Copp, M. R. McNeil, M. A. Wilson, and C. E. Barry III. 2004. The transcriptional responses of M. tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J. Biol. Chem. 279:40174-40184.
26. Bouley, D. M., N. Ghori, K. L. Mercer, S. Falkow, and L. Ramakrishnan. 2001. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect. Immun. 69:7820-7831.
27. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64:29-63.
28. Brooun, A., S. Liu, and K. Lewis. 2000. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 44:640-646.
29. Brosch, R., S. V. Gordon, M. Marmiesse, P. Brodin, C. Buchrieser, K. Eiglmeier, T. Garnier, C. Gutierrez, G. Hewinson, K. Kremer, L. M. Parsons, A. S. Pym, S. Samper, D. van Soolingen, and S. T. Cole. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99:3684-3689.
30. Bryk, R., P. Griffin, and C. Nathan. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407:211-215.
31. Buchmeier, N. A., C. J. Lipps, M. Y. So, and F. Heffron. 1993. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol. Microbiol. 7:933-936.
32. Buchmeier, N. A., G. L. Newton, T. Koledin, and R. C. Fahey. 2003. Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol. Microbiol. 47:1723-1732.
33. Burney, S., J. L. Caulfield, J. C. Niles, J. S. Wishnok, and S. R. Tannenbaum. 1999. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat. Res. 424:37-49.
34. Canetti, G. 1955. The tubercle bacillus in the pulmonary lesion of man. Springer Publishing Co., Inc., New York, N.Y.
35. Canetti, G., M. Le Lirzin, G. Porven, N. Rist, and F. Grumbach. 1968. Some comparative aspects of rifampicin and isoniazid. Tubercle 49:367-376.
36. Carret, G., J. P. Flandrois, and J. R. Lobry. 1991. Biphasic kinetics of bacterial killing by quinolones. J. Antimicrob. Chemother. 27:319-327.
37. Cashel, M., D. R. Gentry, V. H. Hernandez, and D. Vinella. 1996. The stringent response, p. 1458-1496. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. Low, Jr., B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology. ASM Press, Washington, D.C.
38. Chan, J., and J. L. Flynn. 1999. Nitric oxide in Mycobacterium tuberculosis infection, p. 281-310. In F. Fang (ed.), Nitric oxide and infection. Plenum, New York, N.Y.
39. Chan, J., and S. H. E. Kaufmann. 1994. Immune mechanisms of protection, p. 389-415. In B. R. Bloom (ed.), Tuberculosis: pathogenesis, protection and control. ASM Press, Washington, D.C.
40. Chan, J., T. Fujiwara, P. Brennan, M. McNeil, S. J. Turco, J. C. Sibille, M. Snapper, P. Aisen, and B. R. Bloom. 1989. Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc. Natl. Acad. Sci. USA 86:2453-2457.
41. Chan, J., X. D. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59:1755-1761.
42. Chang, D. E., D. J. Smalley, and T. Conway. 2002. Gene expression profiling of Escherichia coli growth transitions: an expanded stringent response model. Mol. Microbiol. 45:289-306.
43. Chen, L., Q. W. Xie, and C. Nathan. 1998. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol. Cell 1:795-805.
44. Choudhuri, B. S., S. Bhakta, R. Barik, J. Basu, M. Kundu, and P. Chakrabarti. 2002. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem. J. 367:279-285.
45. Christensen, S. K., and K. Gerdes. 2003. RelE toxins from bacteria and archaea cleave mRNAs on translating ribosomes, which are rescued by tmRNA. Mol. Microbiol. 48:1389-1400.
46. Christensen, S. K., K. Pedersen, F. G. Hansen, and K. Gerdes. 2003. Toxin-antitoxin loci as stress-response elements: ChpAK/MazF and ChpBK cleave translated RNAs and are counteracted by tmRNA. J. Mol. Biol. 332:809-819.
47. Christensen, S. K., M. Mikkelsen, K. Pedersen, and K. Gerdes. 2001. RelE, a global inhibitor of translation, is activated during nutritional stress. Proc. Natl. Acad. Sci. USA 98:14328-14333.
48. Chua, J., I. Vergne, S. Master, and V. Deretic. 2004. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. Curr. Opin. Microbiol. 7:71-77.
49. Cohen, T., and M. Murray. 2004. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat. Med. 10:1117-1121.
50. Cohen, T., B. Sommers, and M. Murray. 2003. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect. Dis. 3:13-21.
51. Cohen, T., M. C. Becerra, and M. B. Murray. 2004. Isoniazid resistance and the future of drug-resistant tuberculosis. Microb. Drug Resist. 10:280-285.
52. Colangeli, R., D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M. H. Hazbon, R. Harbacheuski, N. J. Megjugorac, W. R. Jacobs, Jr., A. Holzenburg, J. C. Sacchettini, and D. Alland. 2005. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol. Microbiol. 55:1829-1840.
53. Cole, S. T., K. Eiglmeier, J. Parkhill, K. D. James, N. R. Thomson, P. R. Wheeler, N. Honoré, T. Garnier, C. Churcher, D. Harris, K. Mungall, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. M. Davies, K. Devlin, S. Duthoy, T. Feltwell, A. Fraser, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, C. Lacroix, J. Maclean, S. Moule, L. Murphy, K. Oliver, M. A. Quail, M. A. Rajandream, K. M. Rutherford, S. Rutter, K. Seeger, S. Simon, M. Simmonds, J. Skelton, R. Squares, S. Squares, S. Stevens, K. Taylor, S. Whitehead, J. R. Woodward, and B. G. Barrell. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007-1011.
54. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. Gordon, K. Eiglmeier, S. Gas, C. E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M. A. Quail, M. A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J. E. Sulston, J. Taylor, S. Whitehead, and B. G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
55. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-1021.
56. Corbett, E. L., S. Charalambous, K. Fielding, T. Clayton, R. J. Hayes, K. M. De Cock, and G. J. Churchyard. 2003. Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB. J. Infect. Dis. 188:1156-1163.
57. Corbett, E. L., S. Charalambous, V. M. Moloi, K. Fielding, A. D. Grant, C. Dye, K. M. De Cock, R. J. Hayes, B. G. Williams, and G. J. Churchyard. 2004. Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am. J. Respir. Crit. Care Med. 170:673-679.
58. Cosma, C. L., D. R. Sherman, and L. Ramakrishnan. 2003. The secret lives of pathogenic mycobacteria. Annu. Rev. Microbiol. 57:641-676.
59. Cunningham, A. F., and C. L. Spreadbury. 1998. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J. Bacteriol. 180:801-808.
60. Mtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice. Proc. Natl. Acad. Sci. USA 100:10026-10031.
61. Dale, J. W. 1995. Mobile genetic elements in mycobacteria. Eur. Respir. J. Suppl. 20:633s-648s.
62. Dannenberg, A. M., Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Prac. 28:51-58.
63. Darwin, K. H., and C. F. Nathan. 2005. Role for nucleotide excision repair in virulence of Mycobacterium tuberculosis. Infect. Immun. 73:4581-4587.
64. David, H. L. 1970. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol. 20:810-814.
65. Davies, A. P., O. J. Billington, B. A. Bannister, W. R. Weir, T. D. McHugh, and S. H. Gillespie. 2000. Comparison of fitness of two isolates of Mycobacterium tuberculosis, one of which had developed multi-drug resistance during the course of treatment. J. Infect. 41:184-187.
66. Davis, E. O., E. M. Dullaghan, and L. Rand. 2002. Definition of the mycobacterial SOS box and use to identify LexA-regulated genes in Mycobacterium tuberculosis. J. Bacteriol. 184:3287-3295.
67. Denamur, E., S. Bonacorsi, A. Giraud, P. Duriez, F. Hilali, C. Amorin, E. Bingen, A. Andremont, B. Picard, F. Taddei, and I. Matic. 2002. High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J. Bacteriol. 184:605-609.
68. Derbyshire, K. M., and S. Bardarov. 2000. DNA transfer in mycobacteria: conjugation and transduction, p. 93-107. In G. F. Hatfull and W. R. Jacobs, Jr. (ed.), Molecular genetics of mycobacteria. ASM Press, Washington, D.C.
69. Deretic, V., and R. A. Fratti. 1999. Mycobacterium tuberculosis phagosome. Mol. Microbiol. 31:1603-1609.
70. Deretic, V., W. Phillip, S. Dhandayuthapani, M. H. Mudd, R. Curcic, T. Garbe, B. Heym, L. E. Via, and S. T. Cole. 1995. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid. Mol. Microbiol. 17:889-900.
71. De Rossi, E., M. Branzoni, R. Cantoni, A. Milano, G. Riccardi, and O. Ciferri. 1998. mmr, a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors. J. Bacteriol. 180:6068-6071.
72. De Voss, J. J., K. Rutter, B. G. Schroeder, H. Su, Y. Zhu, and C. E. Barry, III. 2000. The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc. Natl. Acad. Sci. USA 97:1252-1257.
73. Dhandayuthapani, S., Y. Zhang, M. H. Mudd, and V. Deretic. 1996. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of AhpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aurum and M. tuberculosis. J. Bacteriol. 178:3641-3649.
74. Dubnau, E., P. Fontan, R. Manganelli, S. Soares-Appel, and I. Smith. 2002. Mycobacterium tuberculosis genes induced during infection of human macrophages. Infect. Immun. 70:2787-2795.
75. Durbach, S. I., B. Springer, E. E. Machowski, R. J. North, K. G. Papavinasasundaram, M. J. Colston, E. C. Böttger, and V. Mizrahi. 2003. DNA alkylation damage as a sensor of nitrosative stress in Mycobacterium tuberculosis. Infect. Immun. 71:997-1000.
76. Dye, C., C. J. Watt, D. M. Bleed, S. M. Hosseini, and M. C. Raviglione. 2005. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293:2767-2775.
77. Ehrt, S., M. U. Shiloh, J. Ruan, M. Choi, S. Gunzburg, C. Nathan, Q. Xie, and L. W. Riley. 1997. A novel antioxidant gene from Mycobacterium tuberculosis. J. Exp. Med. 186:1885-1896.
78. Elliott, A. M., S. E. Berning, M. D. Iseman, and C. A. Peloquin. 1995. Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema. Tuber. Lung. Dis. 76:463-467.
79. Engelhardt, H., C. Heinz, and M. Niederweis. 2002. A tetrameric porin limits the cell wall permeability of Mycobacterium smegmatis. J. Biol. Chem. 277:37567-37572.
80. Enne, V. I., D. M. Livermore, P. Stephens, and L. M. Hall. 2001. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325-1328.
81. Farmer, P., and J. Y. Kim. 1998. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus." BMJ 317:671-674.
82. Farmer, P., J. Furin, J. Bayona, M. Becerra, C. Henry, H. Hiatt, J. Y. Kim, C. Mitnick, E. Nardell, and S. Shin. 1999. Management of MDR-TB in resource-poor countries. Int. J. Tuberc. Lung Dis. 3:643-645.
83. Fenhalls, G., L. Stevens, L. Moses, J. Bezuidenhout, J. C. Betts, P. van Helden, P. T. Lukey, and K. Duncan. 2002. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect. Immun. 70:6330-6338.
84. Fisher, M. A., B. B. Plikaytis, and T. M. Shinnick. 2002. Microarray analysis of the Mycobacterium tuberculosis transcriptional response to the acidic conditions found in phagosomes. J. Bacteriol. 184:4025-4032.
85. Fleischmann, R. D., D. Alland, J. A. Eisen, L. Carpenter, O. White, J. Peterson, R. DeBoy, R. Dodson, M. Gwinn, D. Haft, E. Hickey, J. F. Kolonay, W. C. Nelson, L. A. Umayam, M. Ermolaeva, S. L. Salzberg, A. Delcher, T. Utterhack, J. Weidman, H. Khouri, J. Gill, A. Mikula, W. Bishai, W. R. Jacobs, Jr., J. C. Venter, and C. M. Fraser. 2002. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 184:5479-5490.
86. Flint, J. L., J. C. Kowalski, P. K. Karnati, and K. M. Derbyshire. 2004. The RD1 virulence locus of Mycobacterium tuberculosis regulates DNA transfer in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 101:12598-12603.
87. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
88. Friedberg, E. C., P. L. Fischhaber, and C. Kisker. 2001. Error-prone DNA polymerases: novel structures and the benefits of infidelity. Cell 107:9-12.
89. Garbe, T. R., N. S. Hibler, and V. Deretic. 1996. Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates. Mol. Med. 2:134-142.
90. Garbe, T. R., N. S. Hibler, and V. Deretic. 1999. Response to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donors. Infect. Immun. 67:460-465.
91. Gerdes, K., P. B. Rasmussen, and S. Molin. 1986. Unique type of plasmid maintenance function: postsegregational killing of plasmid-free cells. Proc. Natl. Acad. Sci. USA 83:3116-3120.
92. Gerdes, K., S. K. Christensen, and A. Løbner-Olesen. 2005. Prokaryotic toxin-antitoxin stress response loci. Nat. Rev. Microbiol. 3:371-382.
93. Gillespie, S. H. 2002. Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective. Antimicrob. Agents Chemother. 46:267-274.
94. Giraud, A., I. Matic, O. Tenaillon, A. Clara, M. Radman, M. Fons, and F. Taddei. 2001. Costs and benefits of high mutation rates: adaptive evolution of bacteria in the mouse gut. Science 291:2606-2608.
95. Giraud, A., M. Radman, I. Matic, and F. Taddei. 2001. The rise and fall of mutator bacteria. Curr. Opin. Microbiol. 4:582-585.
96. Glynn, J. R., J. Whiteiey, P. J. Bifani, K. Kremer, and D. van Soolingen. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg. Infect. Dis. 8:843-849.
97. Gold, B., G. M. Rodriguez, S. A. Marras, M. Pentecost, and I. Smith. 2001. The Mycobacterium tuberculosis IdeR is a dual function regulator that controls transcription of genes involved in iron acquisition, iron storage and survival in macrophages. Mol. Microbiol. 42:851-865.
98. Gomez, J. E., and J. D. McKinney. 2004. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinburgh) 84:29-44.
99. Gong, C., P. Bongiomo, A. Martins, N. C. Stephanou, H. Zhu, S. Shuman, and M. S. Glickman. 2005. Mechanism of nonhomologous end-joining in mycobacteria: a low-fidelity repair system driven by Ku, ligase D and ligase C. Nat. Struct. Mol. Biol. 12:304-312.
100. Green way, D. L., and R. R. England. 1999. The intrinsic resistance of Escherichia coli to various antimicrobial agents requires ppGpp and sigma s. Lett. Appl. Microbiol. 29:323-326.
101. Grosset, J. 2003. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrob. Agents Chemother. 47:833-836.
102. Guerillot, F., G. Carret, and J. P. Flandrois. 1993. Mathematical model for comparison of time-killing curves. Antimicrob. Agents Chemother. 37:1685-1689.
103. Gupta, R., M. C. Raviglione, and M. A. Espinal. 2001. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)? Int. J. Tuberc. Lung Dis. 5:1078-1079.
104. Gupta, S., and D. Chatterji. 2005. Stress responses in mycobacteria. IUBMB Life 57:149-159.
105. Gutacker, M. M., J. C. Smoot, C. A. Lux Migliaccio, S. M. Ricklefs, S. Hua, D. V. Cousins, E. A. Graviss, E. Shashkina, B. N. Kreiswirth, and J. M. Musser. 2002. Genome-wide analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis complex organisms: resolution of genetic relationships among closely related microbial strains. Genetics 162:1533-1543.
106. Hampshire, T., S. Soneji, J. Bacon, B. W. James, J. Hinds, K. Laing, R. A. Stabler, P. D. Marsh, and P. D. Butcher. 2004. Stationary phase gene expression of Mycobacterium tuberculosis following progressive nutrient depletion: a model for persistent organisms. Tuberculosis 84:228-238.
107. Harth, G., and M. A. Horwitz. 1999. Export of recombinant Mycobacterium tuberculosis superoxide dismutase is dependent upon both information in the protein and mycobacterial export machinery. A model for studying export of leaderless proteins by pathogenic mycobacteria. J. Biol. Chem. 274:4281-4292.
108. Hegde, S. S., M. W. Vetting, S. L. Roderick, L. A. Mitchenall, A. Maxwell, H. E. Takiff, and J. S. Blanchard. 2005. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science 308:1480-1483.
109. Heifets, L. B., and G. A. Cangelosi. 1999. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int. J. Tuberc. Lung Dis. 3:564-581.
110. Herbert, D., C. N. Paramasivan, P. Venkatesan, G. Kubendiran, R. Prabhakar, and D. A. Mitchison. 1996. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 40:2296-2299.
111. Hirsh, A. E., A. G. Tsolaki, K. DeRiemer, M. W. Feldman, and P. M. Small. 2004. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc. Natl. Acad. Sci. USA 101:4871-4876.
112. Hobby, G. L., and T. F. Lenert. 1957. The in vitro action of antituberculous agents against multiplying and non-multiplying microbial cells. Am. Rev. Tuberc. 76:1031-1048.
113. Hu, Y. M., J. A. Mangan, J. Dhillon, K. M. Sole, D. A. Mitchison, P. D. Butcher, and A. R. Coates. 2000. Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J. Bacteriol. 182:6358-6365.
114. Iseman, M. D. 1993. Treatment of multidrug-resistant tuberculosis. N. Engl. J. Med. 329:784-791.
115. Iseman, M. D., and L. A. Madsen. 1991. Chronic tuberculous empyema with bronchopleural fistula resulting in treatment failure and progressive drug resistance. Chest 100:124-127.
116. Jaffe, A., T. Ogura, and S. Hiraga. 1985. Effects of the ccd function of the F plasmid on bacterial growth. J. Bacteriol. 163:841-849.
117. Jarlier, V., and H. Nikaido. 1994. Mycobacterial cell wall: structure and role in natural resistance to antibiotics. FEMS Microbiol. Lett. 123:11-18.
118. Jiang, Y., J. Pogliano, D. R. Helinski, and I. Konieczny. 2002. ParE toxin encoded by the broad-host-range plasmid RK2 is an inhibitor of Escherichia coli gyrase. Mol. Microbiol. 44:971-979.
119. Jindani, A., C. J. Doré, and D. A. Mitchison. 2003. The bactericidal and sterilising activities of antituberculosis drugs during the first 14 days. Am. J. Respir. Crit. Care Med. 167:1348-1354.
120. Jindani, A., V. R. Aber, E. A. Edwards, and D. A. Mitchison. 1980. The early bactericidal activity of drugs in patients with pulmonary tuberculosis. Am. Rev. Respir. Dis. 121:939-949.
121. Jishage, M., K. Kvint, V. Shingler, and T. Nyström. 2002. Regulation of sigma factor competition by the alarmone ppGpp. Genes Dev. 16:1260-1270.
122. Kaplan, G., F. A. Post, D. L. Moreira, H. Wainwright, B. N. Kreiswirth, M. Tanverdi, B. Mathema, S. V. Ramaswamy, G. Walther, L. M. Steyn, C. E. Barry III, and L. G. Bekker. 2003. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 71:7099-7108.
123. Karakousis, P. C., T. Yoshimatsu, G. Lamichhane, S. C. Woolwine, E. L. Nuermberger, J. Grosset, and W. R. Bishai. 2004. Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice. J. Exp. Med. 200:647-657.
124. Kato-Maeda, M., J. T. Rhee, T. R. Gingeras, H. Salamon, J. Drenkow, N, Smittipat, and P. M. Small. 2001. Comparing genomes within the species Mycobacterium tuberculosis. Genome Res. 11:547-554.
125. Kaufmann, S. H. E., S. T. Cole, V. Mizrahi, E. Rubin, and C. Nathan. 2005. Mycobacterium tuberculosis and the host response. J. Exp. Med. 201:1693-1697.
126. Kendall, S. L., F. Movahedzadeh, S. C. G. Rison, L. Wernisch, T. Parish, K. Duncan, J. C. Betts, and N. G. Stoker. 2004. The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses. Tuberculosis 84:247-255.
127. Keren, I., D. Shah, A. Spoering, N. Kaldalu, and K. Lewis. 2004. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
128. Kohler, T., M. Michea-Hamzehpour, P. Plesiat, A. L. Kahr, and J. C. Pechere. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41:2540-2543.
129. Korch, S. B., T. A. Henderson, and T. M. Hill. 2003. Characterization of the hipA7 allele of Escherichia coli and evidence that high persistence is governed by (p)ppGpp synthesis. Mol. Microbiol. 50:1199-1213.
130. Kussell, E., R. Kishony, N. Q. Balaban, and S. Leibler. 2005. Bacterial persistence: a model of survival in changing environments. Genetics 169:1807-1814.
131. Lau, Y. L., G. C. Chan, S. Y. Ha, Y. F. Hui, and K. Y. Yuen. 1998. The role of the phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin. Infect. Dis. 26:226-227.
132. Laurie, A. D., L. M. Bernardo, C. C. Sze, E. Skarfstad, A. Szalewska-Palasz, T. Nyström, and V. Shingler. 2003. The role of the alarmone (p)ppGpp in sigma N competition for core RNA polymerase. J. Biol. Chem. 278:1494-1503.
133. Lee, B. Y., and M. A. Horwitz. 1995. Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis. J. Clin. Investig. 96:245-249.
134. Lemaitre, N., W. Sougakoff, C. Truffot-Pernot, and V. Jarlier. 1999. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of pyrazinamidase PncA. Antimicrob. Agents Chemother. 43:1761-1763.
135. Levin, B. R. 2002. Models for the spread of resistant pathogens. Neth. J. Med. 60:58-64.
136. Levin, B. R., V. Perrot, and N. Walker. 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 54:985-997.
137. Lewis, K. 2001. Riddle of biofilm resistance. Antimicrob. Agents Chemother. 45:999-1007.
138. Li, X. Z., and H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64:159-204.
139. Li, X. Z., L. Zhang, and H. Nikaido. 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:2415-2423.
140. Li, Z., C. Kelley, F. Collins, D. Rouse, and S. Morris. 1998. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J. Infect. Dis. 177:1030-1035.
141. Lillebaek, T., A. Dirksen, I. Baess, B. Strunge, V. O. Thomsen, and A. B. Andersen. 2002. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 185:401-404.
142. Lipsitch, M., and B. R. Levin. 1998. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int. J. Tuberc. Lung Dis. 2:187-199.
143. Lipsitch, M., C. T. Bergstrom, and B. R. Levin. 2000. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc. Natl. Acad. Sci. USA 97:1938-1943.
144. Liu, J., H. E. Takiff, and H. Nikaido. 1996. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J. Bacteriol. 178:3791-3795.
145. Loebel, R. O., E. Shorr, and H. B. Richardson. 1933. The influence of adverse conditions upon the respiratory metabolism and growth of human tubercle bacilli. J. Bacteriol. 26:167-200.
146. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
147. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.
148. Maisnier-Patin, S., O. G. Berg, L. Liljas, and D. I. Andersson. 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol. Microbiol. 46:355-366.
149. Makarova, K. S., L. Aravind, N. V. Grishin, I. B. Rogozin, and E. V. Koonin. 2002. A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis. Nucleic Acids Res. 30:482-496.
150. Manca, C., S. Paul, C. E. Barry III, V. H. Freedman, and G. Kaplan. 1999. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect. Immun. 67:74-79.
151. Mariam, D. H., Y. Mengistu, S. E. Hoffner, and D. I. Andersson. 2004. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:1289-1294.
152. Massey, R. C., A. Buckling, and S. J. Peacock. 2001. Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr. Biol. 11:1810-1814.
153. Master, S., T. C. Zahrt, J. Song, and V. Deretic. 2001. Mapping of Mycobacterium tuberculosis katG promoters and their differential expression in infected macrophages. J. Bacteriol. 183:4033-4039.
154. Matic, I., M. Radman, F. Taddei, B. Picard, C. Doit, E. Bingen, E. Denamur, and J. Elion. 1997. Highly variable mutation rates in commensal and pathogenic E. coli. Science 277:1833-1834.
155. McCune, R. M., Jr., W. McDermott, and R. Tompsett. 1956. The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J. Exp. Med. 104:763-802.
156. McCune, R. M., Jr., and R. Tompsett. 1956. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy. J. Exp. Med. 104:737-762.
157. McKenzie, G. J., P. L. Lee, M. J. Lombardo, P. J. Hastings, and S. M. Rosenberg. 2001. SOS mutator DNA polymerase IV functions in adaptive mutation and not adaptive amplification. Mol. Cell 7:571-579.
158. Metzgar, D., and C. Wills. 2000. Evidence for the adaptive evolution of mutation rates. Cell 101:581-584.
159. Middlebrook, G., and M. L. Cohn. 1953. Some observations on the pathogenicity of isoniazid resistant variants of tubercle bacilli. Science 118:297-299.
160. Miller, C., L. E. Thomsen, C. Gaggero, R. Messen, H. Ingmer, and S. N. Cohen. 2004. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305:1629-1631.
161. Mitchison, D. A. 1992. The Garrod Lecture. Understanding the chemotherapy of tuberculosis-current problems. J. Antimicrob. Chemother. 29:477-493.
162. Mizrahi, V., and S. J. Andersen. 1998. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol. Microbiol. 29:1331-1339.
163. Mizrahi, V., M. Buckstein, and H. Rubin. 2005. Nucleic acid metabolism, p. 369-378. In S. T. Cole, K. D. Eisenach, D. N. McMurray, and W. R. Jacobs, Jr. (ed.), Tuberculosis and the tubercle bacillus. ASM Press, Washington, D.C.
164. Morris, R. P., L. Nguyen, J. Gatfield, K. Visconti, K. Nguyen, D. Schnappinger, S. Ehrt, Y. Liu, L. Heifets, J. Pieters, G. Schoolnik, and C. J. Thompson. 2005. Ancestral antibiotic resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 102:12200-12205.
165. Moyed, H. S., and K. P. Bertrand. 1983. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis. J. Bacteriol. 155:768-775.
166. Muñoz-Elías, E. J., J. Timm, T. Botha, W. T. Chan, J. E. Gomez, and J. D. McKinney. 2005. Replication dynamics of Mycobacterium tuberculosis in chronically infected mice. Infect. Immun. 73:546-551.
167. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
168. Mwandumba, H. C., D. G. Russell, M. H. Nyirenda, J. Anderson, S. A. White, M. E. Molyneux, and S. B. Squire. 2004. Mycobacterium tuberculosis resides in nonacidified vacuoles in endocytically competent alveolar macrophages from patients with tuberculosis and HIV infection. J. Immunol. 172:4592-4598.
169. Nathan, C. 1992. Nitric oxide a secretory product of mammalian cells. FASEB J. 6:3051-3064.
170. Nathan, C. 2003. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J. Clin. Investig. 111:769-778.
171. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841-8848.
172. Newton, G. L., K. Arnold, M. S. Price, C. Sherrill, S. B. del Cardayré, Y. Aharonowitz, G. Cohen, J. Davies, R. C. Fahey, and C. Davis. 1996. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J. Bacteriol. 178:1990-1995.
173. Ng, V. H., J. S. Cox, A. O. Sousa, J. D. MacMicking, and J. D. McKinney. 2004. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidase burst. Mol. Microbiol. 52:1291-1302.
174. Nicholson, S., M. Bonecini-Almeida, J. R. L. Silva, C. Nathan, Q. W. Xie, R. Mumford, J. R. Weidner, J. Calaycay, J. Geng, N. Boechat, C. Linhares, W. Rom, and J. L. Ho. 1996. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 184:2293-2302.
175. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
176. Nyka, W. 1967. Method for staining both acid-fast and chromophobic tubercle bacilli with carbolfuschin. J. Bacteriol. 93:1458-1460.
177. Nyka, W. 1974. Studies on the effects of starvation on mycobacteria. Infect. Immun. 9:843-850.
178. Ohmori, H., E. C. Friedberg, R. P. Fuchs, M. F. Goodman, F. Hanaoka, D. Hinkle, T. A. Kunkel, C. W. Lawrence, Z. Livneh, T. Nohmi, L. Prakash, S. Prakash, T. Todo, G. C. Walker, Z. Wang, and R. Woodgate. 2001. The Y family of DNA polymerases. Mol. Cell 8:7-8.
179. Ohno, H., G. Zhu, V. P. Mohan, D. Chu, S. Kohno, W. R. Jacobs, Jr., and J. Chan. 2003. The effects of reactive nitrogen intermediates on gene expression in Mycobacterium tuberculosis. Cell. Microbiol. 5:637-648.
180. Oliver, A. R., P. Canton, F. Campo, F. Baquero, and J. Blazquez. 2000. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251-1253.
181. Ordway, D. J., M. G. Sonnenberg, S. A. Donahue, J. T. Belisle, and I. M. Orme. 1995. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect. Immun. 63:741-743.
182. Quellet, H., Y. Quellet, C. Richard, M. Labarre, B. Wittenberg, J. Wittenberg, and M. Guertin. 2002. Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide. Proc. Natl. Acad. Sci. USA 99:5902-5907.
183. Pablos-Mendez, A. 2000. Working alliance for TB drug development, Cape Town, South Africa, February 8th, 2000. Int. J. Tuberc. Lung Dis. 4:489-490.
184. Pandey, D. P., and K. Gerdes. 2005. Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes. Nucleic Acids Res. 33:966-976.
185. Park, H. D., K. M. Guinn, M. I. Harrell, K. Liao, M. I. Voskuil, M. Tompa, G. K. Schoolnik, and D. R. Sherman. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol. Microbiol. 48:833-843.
186. Parsons, L. M., C. S. Junkowski, and K. M. Derbyshire. 1998. Conjugal transfer of chromosomal DNA in Mycobacterium smegmatis. Mol. Microbiol. 28:571-582.
187. Pedersen, K., A. V. Zavialov, M. Y. Pavlov, J. Elf, K. Gerdes, and M. Ehrenberg. 2003. The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site. Cell 112:131-140.
188. Peh, H. L., A. Toh, B. Murugasu-Oei, and T. Dick. 2001. In vitro activities of mitomycin C against growing and hypoxic dormant bacilli. Antimicrob. Agents Chemother. 45:2403-2404.
189. Phillips, I., E. Culebras, F. Moreno, and F. Baquero. 1987. Induction of the SOS response by new4-quinolones. J. Antimicrob. Chemother. 20:631-638.
190. Piddock, L. J., K. J. Williams, and V. Ricci. 2000. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. J. Antimcrob. Chemother. 45:159-165.
191. Primm, T., S. Andersen, V. Mizrahi, D. Avarbock, H. Rubin, and C. E. Barry III. 2000. The stringent response of Mycobacterium tuberculosis is required for long-term survival. J. Bacteriol. 182:4889-4898.
192. Pym, A. S., B. Saint-Joanis, and S. T. Cole. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70:4955-4960.
193. Rad, M. E., P. Bifanl, C. Martin, K. Kremer, S. Samper, J. Rauzier, B. Kreiswirth, J. Blazquez, J. Jouan, D. van Soolingen, and B. Gicquel. 2003. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg. Infect. Dis. 9:838-845.
194. Raman, S., R. Hazra, C. C. Dascher, and R. N. Husson. 2004. Transcription regulation by the Mycobacterium tuberculosis alternative sigma factor SigD and its role in virulence. J. Bacteriol. 186:6605-6616.
195. Ramaswamy, S., and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79:111-118.
196. Rees, R. J. W., and P. D. Hart. 1961. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br. J. Exp. Pathol. 42:83-88.
197. Ren, L., M. S. Rahman, and M. Z. Humayun. 1999. Escherichia coli cells exposed to streptomycin display a mutator phenotype. J. Bacteriol. 181:1043-1044.
198. Rich, E. A., M. Torres, E. Sada, K. Finegan, B. D. Hamilton, and Z. Toossi. 1997. Mycobacterium tuberculosis (MTB)-stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber. Lung Dis. 78:247-255.
199. Roberts, D. M., R. P. Liao, G. Wisedchaisri, W. G. J. Hol, and D. R. Sherman. 2004. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J. Biol. Chem. 279:23082-23087.
200. Ruan, J., G. St. John, S. Ehrt, L. Riley, and C. Nathan. 1999. noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress. Infect. Immun. 67:3276-3283.
201. Russell, D. G., H. C. Mwandumba, and E. E. Rhoades. 2002. Mycobacterium and the coat of many lipids. J. Cell Biol. 158:421-426.
202. Sander, P., B. Springer, T. Prammananan, A. Sturmfels, M. Kappler, M. Pletschette, and E. C. Böttger. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46:1204-1211.
203. Sander, P., E. C. Böttger, B. Springer, B. Steinmann, M. Rezwan, E. Stavropolous, and M. J. Colston. 2003. A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild type BCG but shows increased genetic stability. Vaccine 21:4124-4127.
204. Sander, P., K. G. Papavinasasundaram, T. Dick, E. Stavropolous, K. Ellrott, B. Springer, M. J. Colston, and E. C. Böttger. 2001. Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model. Infect. Immun. 69:3562-3568.
205. Sassetti, C. M., and E. J. Rubin. 2003. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100:12989-12994.
206. Sassetti, C. M., D. H. Boyd, and E. J. Rubin. 2003. Genes required for mycobacterial growth defined by high-density mutagenesis. Mol. Microbiol. 48:77-84.
207. Schnappinger, D., S. Ehrt, M. I. Voskuil, Y. Liu, J. A. Mangan, I. M. Monahan, G. Dolganov, B. Efron, P. D. Butcher, C. Nathan, and G. K. Schoolnik. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704.
208. Segal, W., and H. Bloch. 1956. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J. Bacteriol. 72:132-141.
209. Sever, J. L., and G. P. Youmans. 1957. Enumeration of viable tubercle bacilli from the organs of nonimmunized and immunized mice. Am. Rev. Tuberc. Pulm. Dis. 76:16-635.
210. Sherman, D. R., K. Mdluli, M. J. Hickey, T. M. Arain, S. L. Morris, C. E. Barry III, and C. K. Stover. 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis. Science 272:1641-1643.
211. Sherman, U. R., M. Voskuil, D. Schnappinger, K. Liao, M. I. Harrell, and G. K. Schoolnik. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proc. Natl. Acad. Sci. USA 98:7534-7539.
212. Sherman, D. R., P. J. Sabo, M. J. Mickey, T. M. Arain, G. G. Mahairas, Y. Yuan, C. E. Barry III, and C. K. Stover. 1995. Disparate responses to oxidative stress in saprophytie and pathogenic mycobacteria. Proc. Natl. Acad. Sci. USA 92:6625-6629.
213. Shi, L., Y. J. Jung, S. Tyagi, M. L. Gennaro, and R. J. North. 2003. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc. Natl. Acad. Sci. USA 100:241-246.
214. Silva, P. E., F. Bigi, M. de la Paz Santangelo, M. I. Romano, C. Martin, A. Cataldi, and J. A. Ainsa. 2001. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 45:800-804.
215. Slayden, R. A., and C. E. Barry III. 2000. The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect. 2:659-669.
216. Spoering, A. L., and K. Lewis. 2001. Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials. J. Bacteriol. 183:6746-6751.
217. Springer, B., S. Master, P. Sander, T. Zahrt, M. McFalone, J. Song, K. G. Papavinasasundaram, M. J. Colston, E. Böttger, and V. Deretic. 2001. Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect. Immun. 69:5967-5973.
218. St. John, G., N. Brot, J. Ruan, H. Erdjument-Bromage, P. Tempst, H. Weisshach, and C. Nathan. 2001. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. USA 98:9901-9906.
219. Styblo, K. 1991. Epidemiology of tuberculosis. In Selected papers of the Royal Netherlands Tuberculosis Association, vol. 24. KNCV Tuberculosis Foundation Press, The Hague, The Netherlands.
220. Sung, H. M., G. Yeamans, C. A. Ross, and R. E. Yasbin. 2003. Roles of YqjH and YqjW, homologs of the Escherichia coli UmuC/DinB or Y superfamily of DNA polymerases, in stationary-phase mutagenesis and UV-induced mutagenesis of Bacillus subtilis. J. Bacteriol. 185:2153-2160.
221. Taddei, F., M. Radman, J. Maynard-Smith, B. Toupance, P. H. Gouyon, and B. Godelle. 1997. Role of mutator alleles in adaptive evolution. Nature 387:700-702.
222. Takiff, H. E., M. Cimino, M. C. Musso, T. Welsbrod, R. Martinez, M. B. Delgado, L. Salazar, B. R. Bloom, and W. R. Jacobs, Jr. 1996. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. USA 93:362-366.
223. Talaat, A. M., R. Lyons, S. T. Howard, and S. A. Johnston. 2004. The temporal expression profile of Mycobacterium tuberculosis infection in mice. Proc. Natl. Acad. Sci. USA 101:4602-4607.
224. Tegova, R., A. Tover, K. Tarassova, M. Tark, and M. Kivisaar. 2004. Involvement of error-prone DNA polymerase IV in stationary-phase mutagenesis in Pseudomonas putida. J. Bacteriol. 186:2735-2744.
225. Tenaillon, O., E. Denamur, and I. Matic. 2004. Evolutionary significance of stress-induced mutagenesis in bacteria. Trends Microbiol. 12:264-270.
226. Tenaillon, O., F. Taddei, M. Radman, and O. Matic. 2001. Second-order selection in bacterial evolution: selection acting on mutation and recombination rates in the course of adaptation. Res. Microbiol. 152:11-16.
227. Timm, J., F. A. Post, L. G. Bekker, G. B. Walther, H. C. Wainwright, R. Manganelli, W. T. Chan, L. Tsenova, B. Gold, I. Smith, G. Kaplan, and J. D. McKinney. 2003. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc. Natl. Acad. Sci. USA 100:14321-14326.
228. Trias, J., and R. Benz. 1994. Permeability of the cell wall of Mycobacterium smegmatis. Mol. Microbiol. 14:283-290.
229. Tsolaki, A. G., A. E. Hirsh, K. DeRiemer, J. A. Enciso, M. Z. Wong, M. Hannan, Y. O. Goguet de la Salmoniere, K. Aman, M. Kato-Maeda, and P. M. Small. 2004. Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains. Proc. Natl. Acad. Sci. USA 101:4865-4870.
230. Tuomanen, E., D. T. Durack, and A. Tomasz. 1986. Antibiotic tolerance among clinical isolates of bacteria. Antimicrob. Agents Chemother. 30:521-527.
231. Venkatesh, R., J. P. Kumar, P. S. Krishna, R. Majunath, and U. Varshney. 2003. Importance of uracil DNA glycosylase in Pseudomonas aeruginosa and Mycobacterium smegmatis, G+C-rich bacteria, in mutation prevention, tolerance to acidified nitrite, and endurance in mouse macrophages. J. Biol. Chem. 278:24350-24358.
232. Visser, J. A. 2002. The fate of microbial mutators. Microbiology 148:1247-1252.
233. Voskuil, M. I. 2004. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis 84:138-143.
234. Voskuil, M. I., D. Schnappinger, K. C. Visconti, M. I. Harrell, G. M. Dolganov, D. R. Sherman, and G. K. Schoolnik. 2003. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J. Exp. Med. 198:705-713.
235. Voskuil, M. I., K. C. Visconti, and G. K. Schoolnik. 2004. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis 84:218-227.
236. Wade, M. M., and Y. Zhang. 2004. Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis. J. Med. Microbiol. 53:769-773.
237. Wagner, R. 2002. Regulation of ribosomal RNA synthesis in E. coli: effects of the global regulator guanosine tetraphosphate (ppGpp). J. Mol. Microbiol. Biotechnol. 4:331-340.
238. Wallis, R. S., S. Patil, S. H. Cheon, K. Edmonds, M. Phillips, M. D. Perkins, M. Joloba, A. Namale, J. L. Johnson, L. Teixeira, R. Dietze, S. Siddiqi, R. D. Mugerwa, K. Eisenach, and J. J. Ellner. 1999. Drug tolerance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:2600-2606.
239. Wang, C. H., C. Y. Liu, H. C. Lin, C. T. Yu, K. F. Chung, and H. P. Kuo. 1998. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 11:809-815.
240. Warren, R. M., T. C. Victor, E. M. Streicher, M. Richardson, N. Beyers, N. C. Gey van Pittius, and P. D. van Helden. 2004. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Care Med. 169:610-614.
241. Wayne, L. G. 1994. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13:908-914.
242. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
243. Wayne, L. G., and H. A. Sramek. 1994. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:2054-2058.
244. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
245. Weldingh, K., I. Rosenkrands, S. Jacobsen, P. B. Rasmussen, M. J. Elhay, and P. Andersen. 1998. Two-dimensional electrophoresis for analysis of Mycobacterium tuberculosis culture filtrate and purification and characterization of six novel proteins. Infect. Immun. 66:3492-3500.
246. Werngren, J., and S. E. Hoffner. 2003. Drug-susceptible Mycobacterium tuberculosis Beijing genotype does not develop mutation-conferred resistance to rifampin at an elevated rate. J. Clin. Microbiol. 41:1520-1524.
247. Wieles, B., S. Nagai, H. G. Wiker, M. Harboe, and T. H. Ottenhoff. 1995. Identification and functional characterization of thioredoxin of Mycobacterium tuberculosis. Infect. Immun. 63:4946-4948.
248. Wilson, M., J. DeRisi, H. H. Kristensen, P. Imboden, S. Rane, P. O. Brown, and G. K. Schoolnik. 1999. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridisation. Proc. Natl. Acad. Sci. USA 96:12833-12838.
249. Wink, D. A., K. S. Kasprzak, C. M. Maragos, R. K. Elespuru, M. Misra, T. M. Dunams, T. A. Cebula, W. H. Koch, A. W. Andrews, J. S. Allen, and L. K. Keefer. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003.
250. Wiuff, C., R. M. Zappala, R. R. Regoes, K. N. Garner, F. Baquero, and B. R. Levin. 2005. Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob. Agents Chemother. 49:1483-1494.
251. World Health Organization. 2004. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1999-2002. World Health Organization, Geneva, Switzerland.
252. World Health Organization. 2005. Global tuberculosis control: surveillance, planning, financing: WHO report 2005. WHO/HTM/TB/2005.349. World Health Organization, Geneva, Switzerland.
253. Wright, B. E. 2004. Stress-directed adaptive mutations and evolution. Mol. Microbiol. 52:643-650.
254. Xie, Z., N. Siddiqi, and E. J. Rubin. 2005. Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 49:4778-4780.
255. Yeiser, B., E. D. Pepper, M. F. Goodman, and S. E. Finkel. 2002. SOS-induced DNA polymerases enhance long-term survival and evolutionary fitness. Proc. Natl. Acad. Sci. USA 99:8737-8741.
256. Zahrt, T. C., and V. Deretic. 2002. Reactive nitrogen and oxygen intermediates and bacterial defenses: unusual adaptations in Mycobacterium tuberculosis. Antioxid. Redox Signal. 4:141-159.
257. Zhang, Y., and D. A. Mitchison. 2003. The curious characteristics of pyrazinamide. Int. J. Tuberc. Lung Dis. 7:6-21.
258. Zhang, Y., J. Zhang, K. P. Hoeflich, M. Ikura, G. Qing, and M. Inouye. 2003. MazF cleaves cellular mRNAs specifically at ACA to block protein synthesis in Escherichia coli. Mol. Cell 12:913-923.
259. Zhang, Y., M. M. Wade, A. Scorpio, H. Zhang, and Z. Sun. 2003. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J. Antimicrob. Chemother. 52:790-795.
260. Zhou, J., Y. Dong, X. Zhao, S. Lee, A. Amin, S. Ramaswamy, J. Domagala, J. M. Musser, and K. Drlica. 2000. Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J. Infect. Dis. 182:517-525.
261. Zhu, L., Y. Zhang, J.-S. Teh, J. Zhang, N. Connell, H. Rubin, and M. Inouye. 2006. Characterization of mRNA interferases from Mycobacterium tuberculosis. J. Biol. Chem. [Online.] doi:10.174/jbc.M512693200.
262. Zhuang, J. C., T. L. Wright, T. DeRojas-Walker, S. R. Tannenbaum, and G. N. Wogan. 2000. Nitric oxide-induced mutations in the HPRT gene of human lymphoblastoid TK6 cells and in Salmonella typhimurium. Environ. Mol. Mutagen. 35:39-47.